• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Global Health R&D
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Innovation Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Effective Altruism Community Growth (Global Health and Wellbeing)
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Global Health R&D
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth (Longtermism)
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Innovation Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Contact Us
    • Stay Updated
  • We’re hiring!

International Vaccine Institute — Cholera Vaccine Clinical Trial

Visit Grantee Site
  • Portfolio Area: Human Health and Wellbeing
  • Focus Area: Scientific Research
  • Organization Name: International Vaccines Institute
  • Amount: $2,500,000

  • Award Date: January 2022

Table of Contents

    Open Philanthropy recommended a grant of $2,500,000 over three years to the International Vaccine Institute (IVI) to support a phase I clinical trial of a conjugate vaccine for cholera. IVI will run the clinical trial in partnership with EuBiologics. The trial will be conducted in South Korea with a focus on safety and tolerability in humans, and will test different doses and formulations for the vaccine.

    This falls within our focus area of scientific research, and specifically within our interest in advancing human health and wellbeing.

    Related Items

    • Human Health and Wellbeing

      International Vaccine Institute — Hepatitis E Vaccine Trial

      Open Philanthropy recommended a grant of $4,000,000 over three years to the International Vaccine Institute (IVI) to support their work on a clinical trial of hecolin, a vaccine...

      Read more
    • Human Health and Wellbeing

      International Vaccines Institute — Schistosomiasis Vaccine Assessment

      Open Philanthropy recommended a grant of $140,000 over two years to the International Vaccines Institute (IVI) to support the assessment of the safety and efficacy of SchistoShield®, a...

      Read more
    • Human Health and Wellbeing

      University of Southern California — Preterm Births Research

      Open Philanthropy recommended a grant of $114,353 to the University of Southern California to support scientific activities, led by Professor Jeffrey Klausner, to understand preterm births in lower- and...

      Read more
    Visit Grantee Site
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    • Stay Updated
    Mailing Address
    Open Philanthropy
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    © Open Philanthropy 2022 Except where otherwise noted, this work is licensed under a Creative Commons Attribution-Noncommercial 4.0 International License. If you'd like to translate this content into another language, please get in touch!